Associated Papers
Comprehensive insights on genetic alterations and immunotherapy prognosis in Chinese melanoma patients.
Jia DD et al.
Scientific Reports, 2024
Multidirectional characterization of cellular composition and spatial architecture in human multiple primary lung cancers.
Wang Y et al.
Cell Death & Disease, 2023
37488117 (PubMed )
Supplement: 41419_2023_5992_MOESM3_ESM.xls › IPM_P1-P10
Clinical utility of liquid biopsy and integrative genomic profiling in early-stage and oligometastatic cancer patients treated with radiotherapy.
Cifuentes GA et al.
British Journal of Cancer, 2023
36550207 (PubMed )
Supplement: 41416_2022_2102_MOESM5_ESM.xlsx › Supplementary_table_2
Precision oncology for intrahepatic cholangiocarcinoma in clinical practice.
Tomczak A et al.
British Journal of Cancer, 2022
35986087 (PubMed )
Supplement: 41416_2022_1932_MOESM6_ESM.xlsx › S2_alterations
Characteristics of and Treatment Strategies for Advanced EGFR-Mutant NSCLC With Concomitant BRAF Variations.
Wei XW et al.
Jto Clinical and Research Reports, 2022
35789792 (PubMed )
Supplement: mmc3.xlsx › Supplementary_Table_1
BRAF and DIS3 Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple Myeloma.
Boyle EM et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2020
Pan-cancer whole-genome analyses of metastatic solid tumours.
Priestley P et al.
Nature, 2019
31645765 (PubMed )
Supplement: 41586_2019_1689_MOESM10_ESM.xlsx › Sheet1
Select a paper to view details